The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Molecular pathology of schizophrenia: more than one disease process?
Open accessAbstract
We have developed a generally applicable method based on CRISPR/Cas9-targeted ultra-long read sequencing (CTLR-Seq) to completely and haplotype-specifically resolve, at base-pair resolution, large, complex, and highly repetitive genomic regions that had been previously impenetrable to next-generation sequencing analysis such as large segmental duplication (SegDup) regions and their associated genome rearrangements that stretch hundreds of kilobases. Our method combines in vitro Cas9-mediated cutting of the genome and pulse-field gel electrophoresis to haplotype-specifically isolate intact large (200-550 kb) target regions that encompass previously unresolvable genomic sequences. These target fragments are then sequenced (amplification-free) to produce ultra-long reads at up to 40x on-target coverage using Oxford nanopore technology, allowing for the complete assembly of the complex genomic regions of interest at single base-pair resolution. We applied CTLR-Seq to resolve the exact sequence of SegDup rearrangements that constitute the boundary regions of the 22q11.2 deletion CNV and of the 16p11.2 deletion and duplication CNVs. These CNVs are among the strongest known risk factors for schizophrenia and autism. We then perform de novo assembly to resolve, for the first time, at single base-pair resolution, the sequence rearrangements of the 22q11.2 and 16p11.2 CNVs, mapping out exactly the genes and non-coding regions that are affected by the CNV for different carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Dalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Stereotyped activities produced by amphetamine in several animal species and man
Randrup, A., & Munkvad, I. (1967) · Psychopharmacologia · doi:10.1007/bf00404607 · Cited by 613
A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS
Woolley, D. W., & Shaw, E. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.4.228 · Cited by 602
Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia
Weinberger, D. R. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780070013001 · Cited by 570
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A., & Riley, G. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91740-3 · Cited by 518
Self-citationStein, L., & Wise, C. D. (1971) · Science · doi:10.1126/science.171.3975.1032 · Cited by 477
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Carney, M. W. P., & Price, J. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90193-9 · Cited by 458
Self-citation
Cited by
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
A neuropsychological theory of positive affect and its influence on cognition.
Ashby, F. G., Isen, A. M., & Turken, A. U. (1999) · Psychological Review · doi:10.1037/0033-295x.106.3.529 · Cited by 2,270
Negative v Positive Schizophrenia: Definition and Validation
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,012
Reliability and validity of the apathy evaluation scale
Marin, R. S., Biedrzycki, R. C., & Firinciogullari, S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90040-v · Cited by 1,805
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia
Fletcher, P. C., & Frith, C. D. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2536 · Cited by 1,462
McGuffin, P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320088015 · Cited by 1,483
Context, cortex, and dopamine: A connectionist approach to behavior and biology in schizophrenia.
Cohen, J. D., & Servan-Schreiber, D. (1992) · Psychological Review · doi:10.1037/0033-295x.99.1.45 · Cited by 1,479
The Symptoms of Chronic Schizophrenia: A Re-examination of the Positive-Negative Dichotomy
Liddle, P. F. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.2.145 · Cited by 1,427
The neuropsychology of schizophrenia
Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065055 · Cited by 1,350
Deficit and nondeficit forms of schizophrenia: the concept
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.578 · Cited by 1,332
Sensorimotor Gating and Schizophrenia: Human and Animal Model Studies
Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,309
A neuropsychological theory of multiple systems in category learning.
Ashby, F. G., Alfonso-Reese, L. A., Turken, A. U., & Waldron, E. M. (1998) · Psychological Review · doi:10.1037//0033-295x.105.3.442 · Cited by 1,223
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Apathy: a neuropsychiatric syndrome
(1991) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.3.3.243 · Cited by 1,087
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
A Heuristic Vulnerability/Stress Model of Schizophrenic Episodes
Nuechterlein, K. H., & Dawson, M. E. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.2.300 · Cited by 1,004
The Computational Anatomy of Psychosis
Adams, R. A., Stephan, K. E., Brown, H. R., Frith, C. D., & Friston, K. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00047 · Cited by 850
“This may sound like a very specific assertion; however, there are many converging lines of evidence that point to this conclusion – lines that we try to draw together in this paper.”
BackgroundPatterns of Cerebral Blood Flow in Schizophrenia
Liddle, P. F., Friston, K. J., Frith, C. D., Hirsch, S. R., Jones, T., & Frackowiak, R. S. J. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.179 · Cited by 900
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Leucht, S., Pitschel-Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 796
Optogenetic investigation of neural circuits underlying brain disease in animal models
Tye, K. M., & Deisseroth, K. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3171 · Cited by 745
“Patients with autism and schizophrenia display diverse and variable arrays of symptoms that make the search for a single cause a daunting and possibly unrealistic goa”
BackgroundSymptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen, N. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170015003 · Cited by 734
Stress-reactivity in psychosis: Evidence for an affective pathway to psychosis
Myin-Germeys, I., & van Os, J. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.005 · Cited by 719
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
The role of the cerebellum in schizophrenia
Andreasen, N. C., & Pierson, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.003 · Cited by 669
Frith, C. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700025873 · Cited by 655
Differential diagnosis and classification of apathy
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.1.22 · Cited by 620
Meltzer, H. Y. (1989) · Psychopharmacology · doi:10.1007/bf00442554 · Cited by 602
Vulnerability to psychopathology: A biosocial model.
Zuckerman, M. (1999) · American Psychological Association eBooks · doi:10.1037/10316-000 · Cited by 601
Towards a Neuropsychology of Schizophrenia
Frith, C. D., & Done, D. J. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.153.4.437 · Cited by 595
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias, G., & Remington, G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn094 · Cited by 594
“However, enthusiasm about the treatability of negative symptoms was tempered by a line of thinking suggesting that these features were reflective of underlying morphological changes and, as such, not amenable to pharmacological intervention.(4)”
BackgroundPsychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia
Peralta, V., & Cuesta, M. J. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90093-0 · Cited by 583
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.6.718 · Cited by 564
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 562
Self-citationDefining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms
Andreasen, N. C., Nopoulos, P., O’Leary, D. S., Miller, D. D., Wassink, T., & Flaum, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00152-3 · Cited by 560
Psychophysiology and Psychopathology: A Motivational Approach
Fowles, D. C. (1988) · Psychophysiology · doi:10.1111/j.1469-8986.1988.tb01873.x · Cited by 557
Schizophrenic syndromes, cognitive performance and neurological dysfunction
Liddle, P. F. (1987) · Psychological Medicine · doi:10.1017/s0033291700012976 · Cited by 548
The current conceptualization of negative symptoms in schizophrenia
Marder, S. R., & Galderisi, S. (2017) · World Psychiatry · doi:10.1002/wps.20385 · Cited by 537
Buchsbaum, M. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030001001 · Cited by 535
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Is it possible to be schizophrenic yet neuropsychologically normal?
Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Harris, M. J., Zisook, S., & Jeste, D. V. (1997) · Neuropsychology · doi:10.1037//0894-4105.11.3.437 · Cited by 529
Schizophrenic Syndromes and Frontal Lobe Performance
Liddle, P. F., & Morris, D. L. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.3.340 · Cited by 507
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 499
Horne, J. A. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.3.413 · Cited by 466
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Laruelle, M., & Abi-Dargham, A. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300405 · Cited by 461
Startle response models of sensorimotor gating and habituation deficits in schizophrenia
Geyer, M. A., Swerdlow, N. R., Mansbach, R. S., & Braff, D. L. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90241-q · Cited by 454
Persistent Negative Symptoms in Schizophrenia: An Overview
Buchanan, R. W. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl057 · Cited by 443
Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 436
Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.297 · Cited by 426
Schizophrenia: The Characteristic Symptoms
Andreasen, N. C., & Flaum, M. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.1.27 · Cited by 426
Startle Habituation and Sensorimotor Gating in Schizophrenia and Related Animal Models
Geyer, M. A., & Braff, D. L. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.4.643 · Cited by 413
Positive and Negative Symptoms in Schizophrenia: A Critical Reappraisal
Andreasen, N. C. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810190015002 · Cited by 410
Right hemisphere language functions and schizophrenia: the forgotten hemisphere?
Mitchell, R. L. C. (2005) · Brain · doi:10.1093/brain/awh466 · Cited by 387
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis
Emsley, R., Rabinowitz, J., & Torreman, M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00302-x · Cited by 385
Kegeles, L. S., Abi-Dargham, A., Zea-Ponce, Y., Rodenhiser-Hill, J., Mann, J. J., Van Heertum, R. L., Cooper, T. B., Carlsson, A., & Laruelle, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00976-8 · Cited by 377
The Role of Serotonin in Schizophrenia
Bleich, A., Brown, S.-L., Kahn, R., & van Praag, H. M. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.297 · Cited by 371
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
“Since these studies were performed before the conceptualization of the symptoms of schizophrenia into positive and negative (Crow 1980), they did not formally assess negative symptoms.”
BackgroundVerbal hallucinations and language production processes in schizophrenia
Hoffman, R. E. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00046781 · Cited by 364
Gruzelier, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800310027003 · Cited by 363
Cyclopropane Derivatives and their Diverse Biological Activities
Salaün, J. (2000) · Topics in Current Chemistry · doi:10.1007/3-540-48255-5_1 · Cited by 361
Laruelle, M. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00054-5 · Cited by 358
Suicide risk in schizophrenia: learning from the past to change the future
Pompili, M., Amador, X. F., Girardi, P., Harkavy-Friedman, J., Harrow, M., Kaplan, K., Krausz, M., Lester, D., Meltzer, H. Y., Modestin, J., et al. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-10 · Cited by 358
Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors
Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90327-7 · Cited by 355
Cognitive event-related potential correlates of schizophrenia.
Pritchard, W. S. (1986) · Psychological Bulletin · doi:10.1037//0033-2909.100.1.43 · Cited by 353
Tandon, R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080075010 · Cited by 351
Spitzer, M., Braun, U., Hermle, L., & Maier, S. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90054-h · Cited by 347
Negative Symptoms in Schizophrenia: Their Longitudinal Course and Prognostic Importance
Pogue-Geile, M. F., & Harrow, M. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.427 · Cited by 345
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics
Swerdlow, N. R., Braff, D. L., Geyer, M. A., & Koob, G. F. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90005-3 · Cited by 340
LOHR, J., & FLYNN, K. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90024-y · Cited by 340
A Cognitive Neuroscience View of Schizophrenic Thought Disorder
Spitzer, M. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.1.29 · Cited by 337
Lieberman, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00045-6 · Cited by 333
Natural History of Schizophrenia Subtypes: II. Positive and Negative Symptoms and Long-term Course
Fenton, W. S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350018003 · Cited by 332
Positive vs. Negative Schizophrenia: A Critical Evaluation
Andreasen, N. C. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.380 · Cited by 332
Animal Foraging and the Evolution of Goal‐Directed Cognition
Hills, T. T. (2006) · Cognitive Science · doi:10.1207/s15516709cog0000_50 · Cited by 331
Nieuwenstein, M. R., Aleman, A., & de Haan, E. H. F. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00014-0 · Cited by 326
The diagnostic interview for psychoses (DIP): development, reliability and applications
CASTLE, D. J., JABLENSKY, A., McGRATH, J. J., CARR, V., MORGAN, V., WATERREUS, A., VALURI, G., STAIN, H., McGUFFIN, P., & FARMER, A. (2006) · Psychological Medicine · doi:10.1017/s0033291705005969 · Cited by 324
The impact of environmental factors in severe psychiatric disorders
Schmitt, A., Malchow, B., Hasan, A., & Falkai, P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00019 · Cited by 322
Schizophrenia and brain dysfunction: An integration of recent neurodiagnostic findings.
Seidman, L. J. (1983) · Psychological Bulletin · doi:10.1037//0033-2909.94.2.195 · Cited by 320
Pickar, D. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070059008 · Cited by 318
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum
Kotov, R., Jonas, K. G., Carpenter, W. T., Dretsch, M. N., Eaton, N. R., Forbes, M. K., Forbush, K. T., Hobbs, K., Reininghaus, U., Slade, T., et al. (2020) · World Psychiatry · doi:10.1002/wps.20730 · Cited by 309
The diagnostic concept of schizophrenia: its history, evolution, and future prospects
Jablensky, A. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/ajablensky · Cited by 306
Dopamine receptors in human brain: Autoradiographic distribution of D2 sites
Camps, M., Cortés, R., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90179-6 · Cited by 305
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.466 · Cited by 305
A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170026004 · Cited by 304
Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character
Tamlyn, D., McKenna, P. J., Mortimer, A. M., Lund, C. E., Hammond, S., & Baddeley, A. D. (1992) · Psychological Medicine · doi:10.1017/s0033291700032773 · Cited by 302
Are There More Than Two Syndromes in Schizophrenia?: A Critique of the Positive-Negative Dichotomy
Peralta, V., De Leon, J., & Cuesta, M. J. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.3.335 · Cited by 302
Attentional Vulnerability Indicators, Thought Disorder, and Negative Symptoms
Nuechterlein, K. H., Edell, W. S., Norris, M., & Dawson, M. E. (1986) · Schizophrenia Bulletin · doi:10.1093/schbul/12.3.408 · Cited by 300
Negative Features, Retrieval Processes and Verbal Fluency in Schizophrenia
Allen, H. A., Liddle, P. F., & Frith, C. D. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.163.6.769 · Cited by 288
Honey, G. D., Bullmore, E. T., Soni, W., Varatheesan, M., Williams, S. C. R., & Sharma, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13432 · Cited by 288
Syndromes of Chronic Schizophrenia
Liddle, P. F., & Barnes, T. R. E. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.4.558 · Cited by 287
Cognitive functioning and positive and negative symptoms in schizophrenia
Addington, J., Addington, D., & Maticka-Tyndale, E. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90039-t · Cited by 283
Psychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 273
Metadata
- Authors
- Crow, T. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1980-01-12
- Volume
- 280
- Issue
- 6207
- Pages
- 66-68
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W1970814820
- Cited by
- 1,856
- References
- 37
- FWCI
- 26.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.